ANTIDotE: Anti-tick vaccines to prevent tick-borne diseases in Europe

Parasites and Vectors

Volumn 7, Issue 1, 2014, Pages

  Sprong, Hein ^a   Trentelman, Jos ^b   Seemann, Ingar ^b   Grubhoffer, Libor ^c   Rego, Ryan O M ^c   Hajdušek, Ondřej ^c   Kopáček, Petr ^c   Šíma, Radek ^c   Nijhof, Ard M ^d   Anguita, Juan ^e,i   Winter, Peter ^f   Rotter, Bjorn ^f   Havlíková, Sabina ^g   Klempa, Boris ^g   Schetters, Theo P ^h   Hovius, Joppe W R ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Biology Centre of the Academy of Sciences of the Czech Republic   (Czech Republic)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e CIC BIOGUNE   (Spain)

^f GENXPRO GMBH   (Germany)

^g INSTITUTE OF VIROLOGY   (Slovakia)

^h NV ORGANON   (Netherlands)

ⁱ BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

Babesiosis; Ixodes ricinus; Lyme borreliosis; Public health; Tick borne encephalitis; Vaccine

Indexed keywords

ANTI TICK VACCINE; MICROORGANISM PROTEIN; TICK PROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE; ANTIDOTE; ARTHROPOD PROTEIN; VACCINE;

ARTICLE; DISEASE TRANSMISSION; EUROPE; INFECTION CONTROL; INFECTION PREVENTION; LYME DISEASE; PATHOGENESIS; PROTEIN ANALYSIS; TICK BITE; TICK BORNE DISEASE; TICK BORNE ENCEPHALITIS; ANIMAL; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; TICK; TICK INFESTATIONS; TICK-BORNE DISEASES;

ANIMALIA; BACTERIA (MICROORGANISMS); IXODES RICINUS; IXODIDA;

ANIMALS; ANTIDOTES; ARTHROPOD PROTEINS; EUROPE; HUMANS; TICK INFESTATIONS; TICK-BORNE DISEASES; TICKS; VACCINES;

EID: 84896711114     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-7-77     Document Type: Article

References (35)

1. Lyme borreliosis in Europe. Rizzoli A, Hauffe H, Carpi G, Vourc HG, Neteler M, Rosa R, Euro Surveill 2011 16 27 Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19906
2. Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden. Jaenson TG, Hjertqvist M, Bergstrom T, Lundkvist A, Parasite Vectors 2012 5 184 10.1186/1756-3305-5-184
3. Tick-borne encephalitis-pathogenesis, clinical course and long-term follow-up. Haglund M, Gunther G, Vaccine 2003 21 Suppl 1 11 S18 12628810
4. A clear and present danger: tick-borne diseases in Europe. Heyman P, Cochez C, Hofhuis A, van der Giessen J, Sprong H, Porter SR, Losson B, Saegerman C, Donoso-Mantke O, Niedrig M, Papa A, Expert Rev Anti Infect Ther 2010 8 33 50 10.1586/eri.09.118 20014900
5. A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe. Hovius JW, de Wever B, Sohne M, Brouwer MC, Coumou J, Wagemakers A, Oei A, Knol H, Narasimhan S, Hodiamont CJ, Jahfari S, Pals ST, Horlings HM, Fikrig E, Sprong H, van Oers MH, Lancet 2013 382 658 10.1016/S0140-6736(13)61644-X 23953389
6. Human babesiosis. Martinot M, Zadeh MM, De Briel D, N Engl J Med 2012 367 1070 author reply 1071-1072
7. Upsurge of tick-borne encephalitis in the Baltic States at the time of political transition, independent of changes in public health practices. Sumilo D, Bormane A, Vasilenko V, Golovljova I, Asokliene L, Zygutiene M, Randolph S, Clin Microbiol Infect 2009 15 75 80 10.1111/j.1469-0691.2008.02121.x 19154483
8. Prevalence of Neoehrlichia mikurensis in ticks and rodents from North-west Europe. Jahfari S, Fonville M, Hengeveld P, Reusken C, Scholte EJ, Takken W, Heyman P, Medlock J, Heylen D, Kleve J, Sprong H, Parasite Vectors 2012 5 74 10.1186/1756-3305-5-74
9. Driving forces for changes in geographical distribution of Ixodes ricinus ticks in Europe. Medlock JM, Hansford KM, Bormane A, Derdakova M, Estrada-Pena A, George JC, Golovljova I, Jaenson TG, Jensen JK, Jensen PM, Kazimirova M, Oteo JA, Papa A, Pfister K, Plantard O, Randolph SE, Rizzoli A, Santos-Silva MM, Sprong H, Vial L, Hendrickx G, Zeller H, Van Bortel W, Parasite Vectors 2013 6 1 10.1186/1756-3305-6-1
10. Circumstantial evidence for an increase in the total number and activity of Borrelia-infected Ixodes ricinus in the Netherlands. Sprong H, Hofhuis A, Gassner F, Takken W, Jacobs F, van Vliet AJ, van Ballegooijen M, van der Giessen J, Takumi K, Parasite Vectors 2012 5 294 10.1186/1756-3305-5-294
11. A national case-control study identifies human socio-economic status and activities as risk factors for tick-borne encephalitis in Poland. Stefanoff P, Rosinska M, Samuels S, White DJ, Morse DL, Randolph SE, PLoS One 2012 7 45511 10.1371/journal.pone.0045511 23029063
12. Economic downturn results in tick-borne disease upsurge. Godfrey ER, Randolph SE, Parasite Vectors 2011 4 35 10.1186/1756-3305-4-35
13. Tick-borne encephalitis: the impact of epidemiology, changing lifestyle, and environmental factors. Conference report of the 12th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). Kunze U, TBE I, Vaccine 2011 29 1355 1356 10.1016/j.vaccine.2010.12.048 21199705
14. Public health. Monitoring EU emerging infectious disease risk due to climate change. Lindgren E, Andersson Y, Suk JE, Sudre B, Semenza JC, Science 2012 336 418 419 10.1126/science.1215735 22539705
15. Prevention of tick-borne diseases. Piesman J, Eisen L, Annu Rev Entomol 2008 53 323 343 10.1146/annurev.ento.53.103106.093429 17877457
16. Vaccines against diseases transmitted from animals to humans: a one health paradigm. Monath TP, Vaccine 2013 31 5321 5338 10.1016/j.vaccine.2013.09. 029 24060567
17. A ten-year review of commercial vaccine performance for control of tick infestations on cattle. de la Fuente J, Almazan C, Canales M, de la Lastra JM P, Kocan KM, Willadsen P, Anim Health Res Rev 2007 8 23 28 10.1017/ S1466252307001193 17692140
18. Control of tick infestations and pathogen prevalence in cattle and sheep farms vaccinated with the recombinant Subolesin-major surface protein 1a chimeric antigen. Torina A, Moreno-Cid JA, Blanda V, de Mera IG F, de la Lastra JM, Scimeca S, Blanda M, Scariano ME, Brigano S, Disclafani R, Piazza A, Vicente J, Gortazar C, Caracappa S, Lelli RC, de la Fuente J, Parasite Vectors 2014 7 10 10.1186/1756-3305-7-10
19. Integrated control of Boophilus microplus ticks in Cuba based on vaccination with the anti-tick vaccine Gavac. Valle MR, Mendez L, Valdez M, Redondo M, Espinosa CM, Vargas M, Cruz RL, Barrios HP, Seoane G, Ramirez ES, Boue O, Vigil JL, Machado H, Nordelo CB, Pineiro MJ, Exp Appl Acarol 2004 34 375 382 10.1007/s10493-004-1389-6 15651533
20. High risk of tick bites in dutch gardens. Mulder S, van Vliet AJ, Bron WA, Gassner F, Takken W, Vector Borne Zoonotic Dis 2013 13 865 871 10.1089/vbz.2012.1194 24107214
21. Single-dose vaccine against tick-borne encephalitis. Rumyantsev AA, Goncalvez AP, Giel-Moloney M, Catalan J, Liu Y, Gao QS, Almond J, Kleanthous H, Pugachev KV, Proc Natl Acad Sci U S A 2013 110 13103 13108 10.1073/pnas. 1306245110 23858441
22. Vaccination and tick-borne encephalitis, central Europe. Heinz FX, Stiasny K, Holzmann H, Grgic-Vitek M, Kriz B, Essl A, Kundi M, Emerg Infect Dis 2013 19 69 76 10.3201/eid1901.120458 23259984
23. Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial. Wressnigg N, Pollabauer EM, Aichinger G, Portsmouth D, Low-Baselli A, Fritsch S, Livey I, Crowe BA, Schwendinger M, Bruhl P, Pilz A, Dvorak T, Singer J, Firth C, Luft B, Schmitt B, Zeitlinger M, Muller M, Kollaritsch H, Paulke-Korinek M, Esen M, Kremsner PG, Ehrlich HJ, Barrett PN, Lancet Infect Dis 2013 13 680 689 10.1016/S1473-3099(13)70110-5 23665341
24. Lyme disease vaccination: are we ready to try again? Lantos PM, Lancet Infect Dis 2013 13 643 644 10.1016/S1473-3099(13)70085-9 23665340
25. Interaction of the tick immune system with transmitted pathogens. Hajdusek O, Sima R, Ayllon N, Jalovecka M, Perner J, de la Fuente J, Kopacek P, Front Cell Infect Microbiol 2013 3 26 23875177
26. Identification and characterization of Ixodes scapularis antigens that elicit tick immunity using yeast surface display. Schuijt TJ, Narasimhan S, Daffre S, DePonte K, Hovius JW, Van't Veer C, van der Poll T, Bakhtiari K, Meijers JC, Boder ET, van Dam AP, Fikrig E, PloS One 2011 6 15926 10.1371/journal.pone.0015926 21246036
27. Tick-host-pathogen interactions in Lyme borreliosis. Hovius JW, van Dam AP, Fikrig E, Trends Parasitol 2007 23 434 438 10.1016/j.pt.2007.07.001 17656156
28. Tick vaccines and the transmission of tick-borne pathogens. de la Fuente J, Kocan KM, Blouin EF, Vet Res Commun 2007 31 Suppl 1 85 90 17682852
29. An antivector vaccine protects against a lethal vector-borne pathogen. Labuda M, Trimnell AR, Lickova M, Kazimirova M, Davies GM, Lissina O, Hails RS, Nuttall PA, PLoS Pathog 2006 2 27 10.1371/journal.ppat.0020027 16604154
30. Salivating for knowledge: potential pharmacological agents in tick saliva. Hovius JW, Levi M, Fikrig E, PLoS Med 2008 5 43 10.1371/journal.pmed. 0050043 18271624
31. A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent. Schuijt TJ, Coumou J, Narasimhan S, Dai J, Deponte K, Wouters D, Brouwer M, Oei A, Roelofs JJ, van Dam AP, van der Poll T, Van't Veer C, Hovius JW, Fikrig E, Cell Host Microbe 2011 10 136 146 10.1016/j.chom.2011.06.010 21843870
32. Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agent. Dai J, Wang P, Adusumilli S, Booth CJ, Narasimhan S, Anguita J, Fikrig E, Cell Host Microbe 2009 6 482 492 10.1016/j.chom.2009.10.006 19917502
33. The Lyme disease agent exploits a tick protein to infect the mammalian host. Ramamoorthi N, Narasimhan S, Pal U, Bao F, Yang XF, Fish D, Anguita J, Norgard MV, Kantor FS, Anderson JF, Koski RA, Fikrig E, Nature 2005 436 573 577 10.1038/nature03812 16049492
34. Hypersensitivity to ticks and Lyme disease risk. Burke G, Wikel SK, Spielman A, Telford SR, McKay K, Krause PJ, Tick-borne Infection Study G, Emerg Infect Dis 2005 11 36 41 15705320
35. Towards an integrated approach in surveillance of vector-borne diseases in Europe. Braks M, van der Giessen J, Kretzschmar M, van Pelt W, Scholte EJ, Reusken C, Zeller H, van Bortel W, Sprong H, Parasite Vectors 2011 4 192 10.1186/1756-3305-4-192